HomeQuestion

Does octreotide therapy interfere with the ability to localize an insulinoma via radionuclide diagnostic studies?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Is abnormally elevated estradiol an expected finding in patients with PCOS?

What hormonal workup is recommended for a male with abnormally high serum testosterone not on supplements or hormone replacement therapy?

Would you consider PCSK9 inhibitors for patients with elevated coronary calcium score or coronary calcification for primary prevention in lieu of statins/ezetimibe and/or bempedoic acid?

For patients with rheumatic disease on chronic glucocorticoids, is there a role for alternate-day dosing during tapering, or do you taper by lowering the daily dose only?

Do you recommend concurrent hormone replacement therapy in postmenopausal women on GLP1 R agonist therapy for weight loss given better cardiometabolic outcomes?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.